- Request that one IRB review proposed multisite clinical protocols on behalf of all involved IRBs
- Request single IRB review when adding new site(s) to existing protocols
|Request single or consolidated IRB review for a multi-site study.||IRB Cede Review Request|
The IRB Cede Review Request form supports the Master Reciprocal IRB Reliance Agreement and facilitates multisite human studies. The form may be used for any multisite study that involves at least one Harvard Catalyst-participating institution.
Harvard Catalyst-affiliated investigators may submit a request for ceded IRB review before submitting a full IRB application. The IRBs will review the request and work together to determine whether the proposed research warrants individual regulatory reviews by each institution's IRB, or if review by a single IRB will be sufficient.
MIT-affiliated investigators should first contact Catherine Ricciardi to request an eCommons ID.
Investigators not affiliated with a Harvard Catalyst participating institution may work with a Harvard Catalyst-collaborating investigator to request reliance via the IRB Cede Review Request form or, if not collaborating with a Harvard Catalyst investigator, communicate with their institution's IRB Cede Review Request contact for specific instructions on how to request IRB reliance under the Reciprocal Common Reliance Agreement.
In order to request ceded review, investigators should complete and submit a cede review request prior to submitting their IRB application.
Note that if your computer remains idle for more than 59 minutes while you are completing the Cede Review Form, your data will be lost. You will have the option to save your work at any time and continue later.
Boston Marathon bombing victims participate in a three-year hearing study, thanks to the Harvard Catalyst IRB Cede Review Request System.
Read about how the IRB Cede Review process has helped foster collaborative research across Harvard Catalyst's institutions.